Novel Approaches for Overcoming Biological Barriers
The human body poses various biological barriers to protect itself from pathogens, foreign materials and is important for its functioning and development. This reprint serves as a collection of research and review articles describing novel approaches and new therapeutic modalities to overcome biolog...
Saved in:
| Other Authors: | , |
|---|---|
| Format: | Electronic Book Chapter |
| Language: | English |
| Published: |
Basel
MDPI - Multidisciplinary Digital Publishing Institute
2023
|
| Subjects: | |
| Online Access: | DOAB: download the publication DOAB: description of the publication |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
MARC
| LEADER | 00000naaaa2200000uu 4500 | ||
|---|---|---|---|
| 001 | doab_20_500_12854_100899 | ||
| 005 | 20230623 | ||
| 003 | oapen | ||
| 006 | m o d | ||
| 007 | cr|mn|---annan | ||
| 008 | 20230623s2023 xx |||||o ||| 0|eng d | ||
| 020 | |a books978-3-0365-7698-5 | ||
| 020 | |a 9783036576992 | ||
| 020 | |a 9783036576985 | ||
| 040 | |a oapen |c oapen | ||
| 024 | 7 | |a 10.3390/books978-3-0365-7698-5 |c doi | |
| 041 | 0 | |a eng | |
| 042 | |a dc | ||
| 072 | 7 | |a M |2 bicssc | |
| 072 | 7 | |a KNDP |2 bicssc | |
| 100 | 1 | |a Agrahari, Vibhuti |4 edt | |
| 700 | 1 | |a Kumar, Prashant |4 edt | |
| 700 | 1 | |a Agrahari, Vibhuti |4 oth | |
| 700 | 1 | |a Kumar, Prashant |4 oth | |
| 245 | 1 | 0 | |a Novel Approaches for Overcoming Biological Barriers |
| 260 | |a Basel |b MDPI - Multidisciplinary Digital Publishing Institute |c 2023 | ||
| 300 | |a 1 electronic resource (270 p.) | ||
| 336 | |a text |b txt |2 rdacontent | ||
| 337 | |a computer |b c |2 rdamedia | ||
| 338 | |a online resource |b cr |2 rdacarrier | ||
| 506 | 0 | |a Open Access |2 star |f Unrestricted online access | |
| 520 | |a The human body poses various biological barriers to protect itself from pathogens, foreign materials and is important for its functioning and development. This reprint serves as a collection of research and review articles describing novel approaches and new therapeutic modalities to overcome biological barriers. This collection is a must read for scientists working in the field of drug and vaccine delivery. | ||
| 540 | |a Creative Commons |f https://creativecommons.org/licenses/by/4.0/ |2 cc |4 https://creativecommons.org/licenses/by/4.0/ | ||
| 546 | |a English | ||
| 650 | 7 | |a Medicine |2 bicssc | |
| 650 | 7 | |a Pharmaceutical industries |2 bicssc | |
| 653 | |a blood-brain barrier | ||
| 653 | |a integrity marker | ||
| 653 | |a sorbitol | ||
| 653 | |a positron emission tomography | ||
| 653 | |a focused ultrasound | ||
| 653 | |a zolmitriptan | ||
| 653 | |a intranasal | ||
| 653 | |a bilosomes | ||
| 653 | |a sodium deoxycholate | ||
| 653 | |a mucoadhesive gel | ||
| 653 | |a brain targeting | ||
| 653 | |a blood-brain barrier | ||
| 653 | |a drug formulation | ||
| 653 | |a drug hybrids | ||
| 653 | |a intra-arterial delivery | ||
| 653 | |a intracranial malignancies | ||
| 653 | |a intranasal delivery | ||
| 653 | |a monoterpene | ||
| 653 | |a monoterpenoid | ||
| 653 | |a NEO100 | ||
| 653 | |a carbomer hydrogel | ||
| 653 | |a whitening agents | ||
| 653 | |a enhancers | ||
| 653 | |a enhancement site and mechanism | ||
| 653 | |a drug release and permeation | ||
| 653 | |a inhaled drug delivery | ||
| 653 | |a prodrug | ||
| 653 | |a liposome formulation | ||
| 653 | |a propofol | ||
| 653 | |a micelle | ||
| 653 | |a DSPE mPEG2k | ||
| 653 | |a Solutol HS 15 | ||
| 653 | |a diclofenac | ||
| 653 | |a optimization | ||
| 653 | |a pharmacokinetic | ||
| 653 | |a pharmacodynamic study | ||
| 653 | |a long acting | ||
| 653 | |a sustained delivery | ||
| 653 | |a biologics | ||
| 653 | |a silica microparticles | ||
| 653 | |a exosome | ||
| 653 | |a brain delivery | ||
| 653 | |a BBB crossing | ||
| 653 | |a transcytosis | ||
| 653 | |a peptide-drug conjugates | ||
| 653 | |a blood-placental barrier | ||
| 653 | |a Zika virus | ||
| 653 | |a BBB shuttles | ||
| 653 | |a porphyrins | ||
| 653 | |a antivirals | ||
| 653 | |a epidermal growth factor receptor | ||
| 653 | |a non-small cell lung cancer | ||
| 653 | |a Lamin B2 | ||
| 653 | |a AMPK | ||
| 653 | |a Osimertinib | ||
| 653 | |a RNA seq | ||
| 653 | |a proteomics | ||
| 653 | |a RT-PCR | ||
| 653 | |a blood-brain tumor barrier | ||
| 653 | |a permeabilization | ||
| 653 | |a brain tumors | ||
| 653 | |a primary central nervous system lymphoma | ||
| 653 | |a tumor necrosis factor-alpha | ||
| 653 | |a targeted delivery | ||
| 653 | |a vascular targeting | ||
| 653 | |a CD13 | ||
| 653 | |a TNF | ||
| 653 | |a TNF receptors | ||
| 653 | |a NGR-TNF | ||
| 653 | |a polyamidoamine dendrimers | ||
| 653 | |a diabetic retinopathy | ||
| 653 | |a protein kinase C-β inhibitor | ||
| 653 | |a nanoparticles | ||
| 653 | |a ruboxistaurin | ||
| 653 | |a blood brain barrier | ||
| 653 | |a electropermanent magnet | ||
| 653 | |a magnetic resonance imaging | ||
| 653 | |a n/a | ||
| 856 | 4 | 0 | |a www.oapen.org |u https://mdpi.com/books/pdfview/book/7367 |7 0 |z DOAB: download the publication |
| 856 | 4 | 0 | |a www.oapen.org |u https://directory.doabooks.org/handle/20.500.12854/100899 |7 0 |z DOAB: description of the publication |